Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES（2023）
Key words
EGFRvIII,dimerization,glioblastoma,CAR-T,immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined